Drug Profile
Research programme: nanoparticle therapeutics - LTT Bio-Pharma
Alternative Names: LT-0111; Nano-steroid 1Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator LTT Bio-Pharma
- Class Steroids
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Rheumatoid arthritis
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Rheumatoid-arthritis in Japan
- 17 Aug 2015 LTT Bio-Pharma and Beijing Tide Pharmaceutical agree to co-develop the nano-particle formulation before August 2015 (http://ltt.co.jp/english/souyaku02.html)
- 17 Aug 2015 LTT Bio-Pharma has international patent protection for nanoparticles for drug delivery